Christopher McDougle

Director, Lurie Center for Autism, Massachusetts General Hospital · Cambridge Health Alliance

Credentials: · · · · ·

History

Targeted Pharmacologic Interventions for Autism
National Institute of Mental Health · R01
Contact PI · $734K · Massachusetts General Hospital
2007–2015
1/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD
National Institute of Mental Health · R01
Contact PI · $703.2K · Massachusetts General Hospital
2010–2014
Novel Pharmacological Strategies in Autism
National Institute of Mental Health · R01
Contact PI · $1.6M · Indiana University Indianapolis
2005–2011
Rupp-Pi
National Institute of Mental Health · U10
Contact PI · $2.7M · Indiana University Indianapolis
2002–2008

Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder
Principal investigator · Recruiting · Early phase 1
Christopher John McDougle, M.D.
2026–2029
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Principal investigator · Completed · Phase 4
Yale University
2011–2014
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Principal investigator · Completed · Phase 3
Massachusetts General Hospital
2010–2017
Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism
Principal investigator · Completed · Phase 3
Massachusetts General Hospital
2007–2015